These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10545618)

  • 1. Homocysteine and coronary heart disease: a review of the current evidence.
    Pasceri V; Willerson JT
    Semin Interv Cardiol; 1999 Sep; 4(3):121-8. PubMed ID: 10545618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension?
    Virdis A; Ghiadoni L; Salvetti G; Versari D; Taddei S; Salvett A
    J Nephrol; 2002; 15(4):414-21. PubMed ID: 12243373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Homocysteinemia and coronary artery disease: a case-control study in a Tunisian population].
    Souissi M; Feki M; Mourali S; Enneifer M; Omar S; Sanhaji H; Mechmeche R; Mebazaa A; Kaabachi N
    Arch Mal Coeur Vaiss; 2006 Sep; 99(9):781-5. PubMed ID: 17067095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):935-9. PubMed ID: 15500438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention.
    Woo KS; Qiao M; Chook P; Poon PY; Chan AK; Lau JT; Fung KP; Woo JL
    J Card Surg; 2002; 17(5):432-5. PubMed ID: 12630544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
    Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
    Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
    Moghadasian MH; McManus BM; Frohlich JJ
    Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is homocysteine important as risk factor for coronary heart disease?
    Cesari M; Rossi GP; Sticchi D; Pessina AC
    Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):140-7. PubMed ID: 15871863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of homocysteine in percutaneous coronary interventions (PCI): review of current evidence and plausibility of action.
    Stanger O
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):953-88. PubMed ID: 15704259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia in patients with coronary artery disease.
    Mahanonda N; Leowatana W; Bhuripanyo K; Samranthin M; Kangkagate C
    J Med Assoc Thai; 2000 Nov; 83(11):1354-60. PubMed ID: 11215866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine and oxidative stress.
    Perna AF; Ingrosso D; De Santo NG
    Amino Acids; 2003 Dec; 25(3-4):409-17. PubMed ID: 14661100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection does not affect the serum level of homocysteine.
    Yoshino N; Adachi K; Takashima T; Miyaoka Y; Yuki T; Ishihara S; Kinoshita Y
    Am J Gastroenterol; 2002 Nov; 97(11):2927-8. PubMed ID: 12425577
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
    Sainani GS; Sainani R
    J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of erythrocyte sensitivity to oxidative stress by transient hyperhomocysteinemia in healthy subjects and in patients with coronary artery disease.
    Vesentini N; Kusmic C; Battaglia D; Taddei MC; Barsanti L; Parodi O; Palombo C; Paolicchi A; Barsacchi R
    Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):402-7. PubMed ID: 18029159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.